|

Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

RECRUITINGSponsored by Universitair Ziekenhuis Brussel
Actively Recruiting
SponsorUniversitair Ziekenhuis Brussel
Started2021-01-01
Est. completion2030-01-01
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06333327

Summary

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* symptomatic atrial fibrillation with indication to catheter ablation

Exclusion Criteria:

* age \<18 years old
* pregnancy
* any contraindications to catheter ablation

Conditions2

Atrial FibrillationHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.